Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification

Journal of Cancer

Volumn 4, Issue 3, 2013, Pages 251-261

  Backman, Vadim ^a   Roy, Hemant K ^b  

^a Northwestern University   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

Colon cancer; Field effect; LEBS; Light scattering; PWS; Spectroscopy

Indexed keywords

ORNITHINE DECARBOXYLASE; PROTEIN KINASE C;

CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; CHROMATIN STRUCTURE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONFOCAL MICROSCOPY; EPIGENETICS; GENE EXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; LIFESTYLE MODIFICATION; MICROARRAY ANALYSIS; NONHUMAN; PATIENT MONITORING; REVIEW; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; ULTRASTRUCTURE;

EID: 84882961639     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.5838     Document Type: Review

References (56)

1. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007; 318: 1108-13.
2. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, et al. Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy. New England Journal of Medicine. 2012; 366: 2345-57. doi:10.1056/NEJMoa1114635.
3. Lieberman DA, Weiss DG, Harford WV, Ahnen DJ, Provenzale D, Sontag SJ, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007; 133: 1077-85.
4. Singh H, Turner D, Xue L, Targownik LE, Bernstein CN. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. Jama. 2006; 295: 2366-73.
5. Verhest A, Kiss R, d'Olne D, Larsimont D, Salmon I, de Launoit Y, et al. Characterization of human colorectal mucosa, polyps, and cancers by means of computerized morphonuclear image analyses. Cancer. 1990; 65: 2047-54.
6. Weyn B, Jacob W, da Silva VD, Montironi R, Hamilton PW, Thompson D, et al. Data representation and reduction for chromatin texture in nuclei from premalignant prostatic, esophageal, and colonic lesions. Cytometry. 2000; 41: 133-8.
7. Alberts DS, Einspahr JG, Krouse RS, Prasad A, Ranger-Moore J, Hamilton P, et al. Karyometry of the colonic mucosa. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2704-16.
8. McGarrity TJ, Peiffer LP. Protein kinase C activity as a potential marker for colorectal neoplasia. Dig Dis Sci. 1994; 39: 458-63.
9. McGarrity TJ, Peiffer LP, Bartholomew MJ, Pegg AE. Colonic polyamine content and ornithine decarboxylase activity as markers for adenomas. Cancer. 1990; 66: 1539-43.
10. Vucenik I, Gotovac J, Druzijanic N, Shamsuddin AM. Usefulness of galactose oxidase-Schiff test in rectal mucus for screening of colorectal malignancy. Anticancer Res. 2001; 21: 1247-55.
11. Payne CM, Holubec H, Bernstein C, Bernstein H, Dvorak K, Green SB, et al. Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2066-75.
12. Anti M, Marra G, Armelao F, Percesepe A, Ficarelli R, Ricciuto GM, et al. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. Gut. 1993; 34: 525-30.
13. Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, Sampliner RE, et al. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res. 1999; 59: 2353-7.
14. Chen L, Hao C, Chiu Y, Wong P, Melnick J, Brotman M, et al. Alteration of Gene Expression in Normal-Appearing Colon Mucosa of APCmin Mice and Human Cancer Patients. Cancer Research. 2004; 64: 3694-700.
15. Hao CY, Moore DH, Chiu YS, Wong P, Bennington JL, Smith AP, et al. Altered gene expression in normal colonic mucosa of individuals with polyps of the colon. Dis Colon Rectum. 2005; 48: 2329-35.
16. Cui H, Cruz-Correa M, Giardiello FM, Hutcheon DF, Kafonek DR, Brandenburg S, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science. 2003; 299: 1753-5.
17. Daniel CR, Bostick RM, Flanders WD, Long Q, Fedirko V, Sidelnikov E, et al. TGF-alpha expression as a potential biomarker of risk within the normal-appearing colorectal mucosa of patients with and without incident sporadic adenoma. Cancer Epidemiol Biomarkers Prev. 2009; 18: 65-73.
18. Keku TO, Sandler RS, Simmons JG, Galanko J, Woosley JT, Proffitt M, et al. Local IGFBP-3 mRNA expression, apoptosis and risk of colorectal adenomas. BMC Cancer. 2008; 8: 143.
19. Polley AC, Mulholland F, Pin C, Williams EA, Bradburn DM, Mills SJ, et al. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. . Cancer Res. 2006; 66: 6553-62.
20. Gomes AJ, Roy HK, Turzhitsky V, Kim Y, Rogers JD, Ruderman S, et al. Rectal Mucosal Microvascular Blood Supply Increase Is Associated with Colonic Neoplasia. Clinical Cancer Research. 2009; 15: 3110-7. doi:10.1158/1078-0432.ccr-08-2880.
21. Roy HK, Gomes AJ, Ruderman S, Bianchi LK, Goldberg MJ, Stoyneva V, et al. Optical Measurement of Rectal Microvasculature as an Adjunct to Flexible Sigmoidosocopy: Gender-Specific Implications. Cancer Prevention Research. 2010; 3: 844-51. doi:10.1158/1940-6207.capr-09-0254.
22. Roy HK, Gomes A, Turzhitsky V, Goldberg MJ, Rogers J, Ruderman S, et al. Spectroscopic microvascular blood detection from the endoscopically normal colonic mucosa: Biomarker for neoplasia risk. Gastroenterology. 2008; 135: 1069-78. doi:10.1053/j.gastro.2008.06.046.
23. Albini A, Noonan DM, Ferrari N. Molecular pathways for cancer angioprevention. Clinical Cancer Research. 2007; 13: 4320-5. doi:10.1158/1078-0432.ccr-07-0069.
24. Fudenberg G, Getz G, Meyerson M, Mirny LA. High order chromatin architecture shapes the landscape of chromosomal alterations in cancer. Nature Biotechnology. 2011; 29: 1109-U75. doi:10.1038/nbt.2049.
25. Michor F, Liphardt J, Ferrari M, Widom J. What does physics have to do with cancer? Nature Reviews Cancer. 2011; 11: 657-70. doi:10.1038/nrc3092.
26. Kim JS, Backman V, Szleifer I. Crowding-Induced Structural Alterations of Random-Loop Chromosome Model. Physical Review Letters. 2011;106(16):168102. doi:16810210.1103/PhysRevLett.106.168102.
27. Barker HE, Cox TR, Erler JT. The rationale for targeting the LOX family in cancer. Nature Reviews Cancer. 2012; 12: 540-152. doi:10.1038/nrc3319.
28. Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, et al. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nature Medicine. 2010; 16: 1009-U107. doi:10.1038/nm.2208.
29. Black JC, Whetstine JR. LOX Out, Histones: A New Enzyme Is Nipping at Your Tails. Molecular Cell. 2012; 46: 243-4. doi:10.1016/j.molcel.2012.04.023.
30. Potter JD. Morphostats: A missing concept in cancer biology. Cancer Epidemiology Biomarkers & Prevention. 2001; 10: 161-70.
31. Potter JD. Morphogens, morphostats, microarchitecture and malignancy. Nature Reviews Cancer. 2007; 7: 464-74. doi:10.1038/nrc2146.
32. Baker SG, Soto AM, Sonnenschein C, Cappuccio A, Potter JD, Kramer BS. Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats. BMC Cancer. 2009;9:89. doi:8910.1186/1471-2407-9-89.
33. Finlay JC, Foster TH. Effect of pigment packaging on diffuse reflectance spectroscopy of samples containing red blood cells. Optics Letters. 2004; 29: 965-7. doi:10.1364/ol.29.000965.
34. Turzhitsky VM, Gomes AJ, Kim YL, Liu Y, Kromine A, Rogers JD, et al. Measuring mucosal blood supply in vivo with a polarization-gating probe. Applied Optics. 2008; 47: 6046-57.
35. Radosevich AJ, Turzhitsky VM, Mutyal NN, Rogers JD, Stoyneva V, Tiwari AK, et al. Depth-resolved measurement of mucosal microvascular blood content using low-coherence enhanced backscattering spectroscopy. Biomedical Optics Express. 2010; 1: 1196-208. doi:10.1364/boe.1.001196.
36. Rogers JD, Capoglu IR, Backman V. Nonscalar elastic light scattering from continuous random media in the Born approximation. Optics Letters. 2009; 34: 1891-3.
37. Kim JS, Pradhan P, Backman V, Szleifer I. The influence of chromosome density variations on the increase in nuclear disorder strength in carcinogenesis. Physical Biology. 2011 Feb;8(1):015004. doi:015004 10.1088/1478-3975/8/1/015004.
38. Itzkan I, Qiu L, Fang H, Zaman MM, Vitkin E, Ghiran LC, et al. Confocal light absorption and scattering spectroscopic microscopy monitors organelles in live cells with no exogenous labels. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104: 17255-60. doi:10.1073/pnas.0708669104.
39. Subramanian H, Roy HK, Pradhan P, Goldberg MJ, Muldoon J, Brand RE, et al. Nanoscale Cellular Changes in Field Carcinogenesis Detected by Partial Wave Spectroscopy. Cancer Research. 2009; 69: 5357-63. doi:10.1158/0008-5472.can-08-3895.
40. Gomes AJ, Ruderman S, DelaCruz M, Wali RK, Roy HK, Backman V. In vivo measurement of the shape of the tissue-refractive-index correlation function and its application to detection of colorectal field carcinogenesis. Journal of Biomedical Optics. 2012 Apr;17(4):047005. doi:04700510.1117/1.jbo.17.4.047005.
41. Radosevich AJ, Mutyal NN, Turzhitsky V, Rogers JD, Yi J, Taflove A, et al. Measurement of the spatial backscattering impulse-response at short length scales with polarized enhanced backscattering. Optics Letters. 2011; 36: 4737-9.
42. Turzhitsky V, Radosevich AJ, Rogers JD, Mutyal NN, Backman V. Measurement of optical scattering properties with low-coherence enhanced backscattering spectroscopy. Journal of Biomedical Optics. 2011 Jun;16(6):067007. doi:06700710.1117/1.3589349.
43. Radosevich AJ, Rogers JD, Turzhitsky V, Mutyal NN, Yi J, Roy HK, et al. Polarized Enhanced Backscattering Spectroscopy for Characterization of Biological Tissues at Subdiffusion Length Scales. Ieee Journal of Selected Topics in Quantum Electronics. 2012; 18: 1313-06725.
44. Roy HK, Liu Y, Wali RK, Kim YL, Kromine AK, Goldberg MJ, et al. Four-dimensional elastic light-scattering fingerprints as preneoplastic markers in the rat model of colon carcinogenesis. Gastroenterology. 2004; 126: 1071-81. doi:10.1053/j.gastro.2004.01.009.
45. Roy HK, Kim YL, Wali RK, Liu Y, Koetsier J, Kunte DP, et al. Spectral markers in preneoplastic intestinal mucosa: An accurate predictor of tumor risk in the MIN mouse. Cancer Epidemiology Biomarkers & Prevention. 2005; 14: 1639-45.
46. Tiwari AK, Crawford SE, Radosevich A, Wali RK, Stypula Y, Kunte DP, et al. Neo-angiogenesis and the premalignant micro-circulatory augmentation of early colon carcinogenesis. Cancer Letters. 2011; 306: 205-13. doi:10.1016/j.canlet.2011.03.008.
47. Roy HK, Wali RK, Kim Y, Liu Y, Hart J, Kunte DP, et al. Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis. FEBS Letters. 2007; 581: 3857-62. doi:10.1016/j.febslet.2007.07.012.
48. Mutyal NN, Radosevich A, Gould B, Rogers JD, Gomes A, Turzhitsky V, et al. A fiber optic probe design to measure depthlimited optical properties in-vivo with Lowcoherence Enhanced Backscattering (LEBS) Spectroscopy. Optics Express. 2012; 20: 19643-57.
49. Roy HK, Turzhitsky V, Kim Y, Goldberg MJ, Watson P, Rogers JD, et al. Association between Rectal Optical Signatures and Colonic Neoplasia: Potential Applications for Screening. Cancer Research. 2009; 69: 4476-83. doi:10.1158/0008-5472.can-08-4780.
50. Subramanian H, Pradhan P, Liu Y, Capoglu IR, Li X, Rogers JD, et al. Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells. PNAS. 2008; 105: 20118-23. doi:10.1073/pnas.0804723105.
51. Damania D, Subramanian H, Tiwari AK, Stypula Y, Kunte D, Pradhan P, et al. Role of Cytoskeleton in Controlling the Disorder Strength of Cellular Nanoscale Architecture. Biophysical Journal. 2010; 99: 989-96. doi:10.1016/j.bpj.2010.05.023.
52. Damania D, Roy HK, Subramanian H, Weinberg DS, Rex DK, Goldberg MJ, et al. Nanocytology of Rectal Colonocytes to Assess Risk of Colon Cancer Based on Field Cancerization. Cancer Research. 2012; 72: 2720-7.
53. Nadiarnykh O, LaComb RB, Brewer MA, Campagnola PJ. Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy. BMC Cancer. 2010; 10: 94. doi:9410.1186/1471-2407-10-94.
54. Baker AM, Cox TR, Bird D, Lang G, Murray GI, Sun XF, et al. The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer. Journal of the National Cancer Institute. 2011; 103: 407-24. doi:10.1093/jnci/djq569.
55. Baker A-M, Bird D, Lang G, Cox TR, Erler JT. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene. 2012; epub.
56. Roy HK, Iversen P, Hart J, Liu Y, Koetsier JL, Kim Y, et al. Down-regulation of SNAIL suppresses MIN mouse tumorigenesis: Modulation of apoptosis proliferation, and fractal dimension. Molecular Cancer Therapeutics. 2004; 3: 1159-65.